comparemela.com

Latest Breaking News On - Ferrer incode - Page 1 : comparemela.com

Precision Medicine Market to reach US$ 114,891 Mn by end of 2028, Says Coherent Market Insights

SEATTLE, Oct. 21, 2021 /PRNewswire/ Precision medicine sometimes referred to as "holistic medicine" is a highly specialized way to tailor personalized medicine to specific individuals, taking

Japan
United-states
India
United-kingdom
America
American
Ferrer-incode
Asia-pacific
Indivumed-gmb
Amgen
American-association-for-clinical-chemistry
World-health-organization

Precision Medicine Market to reach US$ 114,891 Mn by end of 2028, Says Coherent Market Insights

/PRNewswire/ Precision medicine sometimes referred to as "holistic medicine" is a highly specialized way to tailor personalized medicine to specific.

Japan
United-states
India
United-kingdom
America
American
Ferrer-incode
Asia-pacific
Indivumed-gmb
Amgen
American-association-for-clinical-chemistry
World-health-organization

Precision Medicine Market to reach US$ 114,891 Mn by end of 2028, Says Coherent Market Insights

/PRNewswire/ Precision medicine sometimes referred to as "holistic medicine" is a highly specialized way to tailor personalized medicine to specific.

Japan
United-states
India
United-kingdom
America
American
Ferrer-incode
Asia-pacific
Indivumed-gmb
Amgen
American-association-for-clinical-chemistry
World-health-organization

Precision Medicine Market 2021 : Take Advantage and Grow – Read These Few Tips – KSU

Precision Medicine MarketAt first, the Global Precision Medicine Market report presents a basic introduction of the industry containing

United-states
United-kingdom
America
Ferrer-incode
Asia-pacific
Merck-co-inc
Pfizer-inc
Nanostring-technologies-inc
Tepnel-pharma-services
Quest-diagnostics
Teva-pharmaceutical-industries-ltd
Global-precision-medicine

Growing Demand, Market Size and Business Outlook of Global Precision Medicine Market – KSU

Global Precision Medicine Market, By  Technology (Bioinformatics, Drug Discovery, Gene Sequencing, Precision Molecular Diagnostics, and Big Data Analytics), By Application (Oncology, CNS, Respiratory, Immunology, Hematology, and Others),   and  By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030.” Key Highlights: In January 2018, Syapse collaborated with Roche in order to advance precision medicine in oncology. Also, this partnership focuses on clinical delivery and product development for introducing precision medicine to more patients. In March 2018, DSM partnered with Mixfit to provide personalized nutrition solutions by combining Artificial Intelligence (AI) technology. Analyst View: Growing demand and advancements in cancer biology will drive personalized medicine market during the forecast period. Accessibility to large-scale human genome database including next-generation sequencing

Australia
Japan
United-states
Argentina
Brazil
China
South-africa
Mexico
Germany
India
New-zealand
Hungary

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.